IR Biosciences Holdings Inc.
IRBS · OTC
12/31/2010 | 9/30/2010 | 6/30/2010 | 3/31/2010 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $402 | $341 | $1,227 | $890 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $402 | $341 | $1,227 | $890 |
| Operating Income | -$402 | -$341 | -$1,227 | -$890 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $58 | -$2,453 | $2,408 | -$2,436 |
| Pre-Tax Income | -$343 | -$2,794 | $1,181 | -$3,326 |
| Tax Expense | $0 | -$4 | $0 | $0 |
| Net Income | -$343 | -$2,790 | $1,181 | -$3,326 |
| % Margin | – | – | – | – |
| EPS | -0.02 | -0.17 | 0.08 | -0.24 |
| % Growth | 88% | -312.5% | 133.3% | – |
| EPS Diluted | -0.02 | -0.17 | 0.08 | -0.24 |
| Weighted Avg Shares Out | 16,831 | 16,831 | 15,308 | 13,892 |
| Weighted Avg Shares Out Dil | 16,831 | 16,831 | 15,308 | 13,892 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $482 | $243 | $495 | $496 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $140 | -$2,549 | $1,679 | -$2,828 |
| % Margin | – | – | – | – |